Evidence map›Paper›PMID 37630570›Full record

ArticleMicroorganisms2023

Kinetics of SARS-CoV-2 Spike Antibodies after the Second and Third Dose of the BNT162b2 COVID-19 Vaccine and Association with Epidemiological Characteristics and Breakthrough Infection in a Cohort Study of Healthcare Workers.

Elizabeth-Barbara Tatsi, Filippos Filippatos, Charilaos Dellis, Maria-Myrto Dourdouna, Vasiliki Syriopoulou, Athanasios Michos

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elizabeth-Barbara TatsiInfectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-7325-6195
Filippos FilippatosInfectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-2775-3670
Charilaos DellisInfectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-6195-0999
Maria-Myrto DourdounaInfectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-9470-8282
Vasiliki SyriopoulouInfectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Athanasios MichosInfectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-1745-1118
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To prospectively study the kinetics of immune responses after immunization with the BNT162b2 mRNA COVID-19 vaccine and their association with epidemiological parameters and breakthrough infection (BI), we measured total (TAbs-WT) and neutralizing antibodies against wild-type (NAbs-WT) and Omicron (NAbs-O) SARS-CoV-2 spike proteins in healthcare workers (HCWs) after the second (4 and 8 months) and third dose (1 and 8 months). Vaccinated HCWs (

Indexed as

BNT162b2breakthrough infectionCOVID-19immunitySARS-CoV-2vaccination

Identifiers

PMID37630570
PMCPMC10458561
OpenAlexW4385576574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.